CeriBell (CBLL) News Today $14.57 -0.31 (-2.08%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$14.60 +0.03 (+0.17%) As of 04/15/2025 06:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Ceribell announces FDA grants clearance for next-gen Ceribell Clarity algorithmApril 16 at 12:10 AM | markets.businessinsider.comFDA Clears Ceribell's Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and OlderApril 15 at 8:00 AM | globenewswire.comBoard of Trustees of The Leland Stanford Junior University Takes Position in CeriBell (NASDAQ:CBLL)Board of Trustees of The Leland Stanford Junior University purchased a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 623,751 shares of the company'sApril 15 at 6:57 AM | marketbeat.comCeribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4April 14 at 8:42 AM | msn.comNext Century Growth Investors LLC Acquires New Stake in CeriBell (NASDAQ:CBLL)Next Century Growth Investors LLC bought a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 204,760 shares of the companyApril 14 at 7:28 AM | marketbeat.comCeribell braces for tariff impact on marginsApril 13 at 7:56 PM | uk.investing.comCeriBell (NASDAQ:CBLL) Shares Gap Up - Here's What HappenedCeriBell (NASDAQ:CBLL) Shares Gap Up - Here's WhyApril 13 at 10:54 AM | marketbeat.comFederated Hermes Inc. Acquires New Position in CeriBell (NASDAQ:CBLL)Federated Hermes Inc. bought a new position in CeriBell (NASDAQ:CBLL - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm bought 372,251 shares of the company's stock, valued at approximately $9,634,000. Federated Hermes Inc. owned approximatApril 13 at 5:17 AM | marketbeat.comCeriBell (NASDAQ:CBLL) Shares Gap Up - Here's WhyApril 13 at 2:49 AM | americanbankingnews.comWilliam Blair maintains Ceribell Outperform amid tariff concernsApril 13 at 12:35 AM | investing.com481,446 Shares in CeriBell (NASDAQ:CBLL) Purchased by Franklin Resources Inc.Franklin Resources Inc. acquired a new stake in shares of CeriBell (NASDAQ:CBLL - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 481,446 shares of the company's stock, valued at approximatelyApril 11, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Hits New 1-Year Low - Here's What HappenedCeriBell (NASDAQ:CBLL) Reaches New 52-Week Low - Here's What HappenedApril 9, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Makes New Investment in CeriBell (NASDAQ:CBLL)Massachusetts Financial Services Co. MA purchased a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 415,361 shares of the company'sApril 9, 2025 | marketbeat.comCeriBell's IPO Lockup Ends April 9 - Here's Why We're Shorting It TodayApril 7, 2025 | seekingalpha.comBrokerages Set CeriBell (NASDAQ:CBLL) Price Target at $32.60April 7, 2025 | americanbankingnews.comCeriBell (NASDAQ:CBLL) Earns Buy Rating from Analysts at LADENBURG THALM/SH SHLADENBURG THALM/SH SH assumed coverage on shares of CeriBell in a research note on Friday. They set a "buy" rating and a $32.00 target price for the company.April 6, 2025 | marketbeat.comLADENBURG THALM/SH SH Begins Coverage on CeriBell (NASDAQ:CBLL)April 6, 2025 | americanbankingnews.comContrasting NeurAxis (NASDAQ:NRXS) & CeriBell (NASDAQ:CBLL)April 6, 2025 | americanbankingnews.comLadenburg Thalmann Initiates Coverage of CeriBell (CBLL) with Buy RecommendationApril 5, 2025 | msn.comCeriBell (NASDAQ:CBLL) Receives Average Rating of "Buy" from BrokeragesCeriBell (NASDAQ:CBLL - Get Free Report) has received a consensus rating of "Buy" from the six ratings firms that are covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have updated theirApril 5, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Hits New 1-Year Low - What's Next?CeriBell (NASDAQ:CBLL) Reaches New 1-Year Low - Here's WhyApril 3, 2025 | marketbeat.comCeriBell's (NASDAQ:CBLL) Lock-Up Period To Expire on April 9thCeriBell's (NASDAQ:CBLL - Get Free Report) lock-up period will expire on Wednesday, April 9th. CeriBell had issued 10,606,060 shares in its initial public offering on October 11th. The total size of the offering was $180,303,020 based on an initial share price of $17.00. After the expiration of the company's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.April 3, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Invests $2.50 Million in CeriBell (NASDAQ:CBLL)Charles Schwab Investment Management Inc. bought a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 96,582 shares of the company's stock, valued at approxMarch 30, 2025 | marketbeat.comBank of New York Mellon Corp Purchases New Holdings in CeriBell (NASDAQ:CBLL)Bank of New York Mellon Corp acquired a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 24,274 shares of the company's stock, valued at appMarch 27, 2025 | marketbeat.comEmerald Advisers LLC Buys New Stake in CeriBell (NASDAQ:CBLL)Emerald Advisers LLC purchased a new stake in shares of CeriBell (NASDAQ:CBLL - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 120,805 shares of the company's stock, valued at approximately $3,126,000. EmeraldMarch 25, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Shares Gap Up - Time to Buy?CeriBell (NASDAQ:CBLL) Shares Gap Up - Still a Buy?March 18, 2025 | marketbeat.comCeribell executives receive pay increases and incentivesMarch 16, 2025 | uk.investing.comCeriBell (NASDAQ:CBLL) Stock Price Down 5.7% - Here's WhyCeriBell (NASDAQ:CBLL) Trading Down 5.7% - Here's WhyMarch 13, 2025 | marketbeat.comRhumbline Advisers Makes New Investment in CeriBell (NASDAQ:CBLL)Rhumbline Advisers bought a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund bought 12,353 shares of the company's stock, valued at approximately $320,000. Analyst Upgrades and DowngradesSeveral broMarch 10, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Shares Up 4.9% - Still a Buy?CeriBell (NASDAQ:CBLL) Trading Up 4.9% - Should You Buy?March 4, 2025 | marketbeat.comCeriBell, Inc. (CBLL) Q4 2024 Earnings Call TranscriptMarch 3, 2025 | seekingalpha.comWilliam Blair Has Negative Forecast for CeriBell Q1 EarningsCeriBell (NASDAQ:CBLL - Free Report) - William Blair decreased their Q1 2025 earnings per share estimates for CeriBell in a report released on Wednesday, February 26th. William Blair analyst M. Andrew now expects that the company will post earnings of ($0.44) per share for the quarter, down fromMarch 1, 2025 | marketbeat.comCanaccord Genuity Group Reaffirms Buy Rating for CeriBell (NASDAQ:CBLL)Canaccord Genuity Group reaffirmed a "buy" rating and set a $33.00 target price on shares of CeriBell in a research note on Wednesday.February 27, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Issues Quarterly Earnings Results, Misses Expectations By $0.08 EPSCeriBell (NASDAQ:CBLL - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.32) by ($0.08).February 26, 2025 | marketbeat.comCeriBell Inc (CBLL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amid ...February 26, 2025 | gurufocus.comQ4 2024 CeriBell Inc Earnings Call TranscriptFebruary 26, 2025 | gurufocus.comCeribell Reports Fourth Quarter and Full Year 2024 Financial ResultsFebruary 25, 2025 | globenewswire.comCeriBell (NASDAQ:CBLL) Shares Up 5.7% - Here's WhyCeriBell (NASDAQ:CBLL) Shares Up 5.7% - Here's WhyFebruary 22, 2025 | marketbeat.comCeriBell: A Leader In AI-Powered Seizure DetectionFebruary 21, 2025 | seekingalpha.comCeriBell (CBLL) to Release Earnings on TuesdayCeriBell (NASDAQ:CBLL) will be releasing earnings after the market closes on Tuesday, February 25, Financial Modeling Prep reports.February 21, 2025 | marketbeat.comCeribell to Participate in the 45th Annual TD Cowen Healthcare ConferenceFebruary 18, 2025 | globenewswire.comCeriBell (NASDAQ:CBLL) Receives Consensus Rating of "Buy" from BrokeragesShares of CeriBell (NASDAQ:CBLL - Get Free Report) have received an average rating of "Buy" from the six research firms that are covering the company, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have coFebruary 13, 2025 | marketbeat.comCeribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025February 11, 2025 | globenewswire.comCeriBell (CBLL) Projected to Post Earnings on TuesdayCeriBell (NASDAQ:CBLL) will be releasing earnings before the market opens on Tuesday, February 11, Financial Modeling Prep reports.February 4, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Trading 9.1% Higher - Should You Buy?CeriBell (NASDAQ:CBLL) Trading 9.1% Higher - Still a Buy?January 21, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Given Average Rating of "Buy" by AnalystsShares of CeriBell (NASDAQ:CBLL - Get Free Report) have been assigned an average recommendation of "Buy" from the six research firms that are presently covering the company, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price objective amonJanuary 19, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Hits New 52-Week Low - Time to Sell?CeriBell (NASDAQ:CBLL) Hits New 12-Month Low - What's Next?January 13, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Trading Down 9.2% - Here's WhyCeriBell (NASDAQ:CBLL) Shares Down 9.2% - Here's What HappenedJanuary 10, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Hits New 52-Week Low - Here's WhyCeriBell (NASDAQ:CBLL) Reaches New 52-Week Low - Here's What HappenedJanuary 6, 2025 | marketbeat.comCeriBell (NASDAQ:CBLL) Trading Down 3.3% - What's Next?CeriBell (NASDAQ:CBLL) Trading Down 3.3% - What's Next?January 3, 2025 | marketbeat.com Remove Ads Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address CBLL Media Mentions By Week CBLL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CBLL News Sentiment▼0.950.79▲Average Medical News Sentiment CBLL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CBLL Articles This Week▼142▲CBLL Articles Average Week Remove Ads Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LivaNova News LeMaitre Vascular News Enovis News NovoCure News CONMED News Warby Parker News Cadre News Kestra Medical Technologies News Liquidia News Tandem Diabetes Care News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CBLL) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.